| Mihok Speech Pathology, Llc | |
|
3155 Richardsville Rd, Bowling Green, KY 42101-0431 | |
| (270) 799-1368 | |
| Not Available |
| Full Name | Mihok Speech Pathology, Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 3155 Richardsville Rd, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306628037 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mihok Speech Pathology, Llc 3155 Richardsville Rd, Bowling Green, KY 42101-0431 Ph: (270) 799-1368 | Mihok Speech Pathology, Llc 3155 Richardsville Rd, Bowling Green, KY 42101-0431 Ph: (270) 799-1368 |
News Archive
Scientists are reporting use of a new technology for sifting through the world's largest remaining pool of potential antibiotics to discover two new antibiotics that work against deadly resistant microbes, including the "super bugs" known as MRSA. Their report appears in the Journal of the American Chemical Society.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the presentation of data from a Phase 2 clinical trial at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) showing encouraging overall survival (OS) results with ARQ 197 in combination with erlotinib among patients with advanced, refractory non-small cell lung cancer.
The first large-scale study testing all the DNA—the entire genome—of tumour cells from more than 400 women with advanced breast cancer has identified individuals with a good chance of benefiting from specific treatments already being tested in clinical trials.
The 2012 Nobel prize-winning discovery that ordinary cells could be coaxed to revert to their earliest pluripotent stage ushered in the era of ethical stem cell research.
Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.
› Verified 9 days ago
Amanda Sadler, M.S. CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5855 Richpond Rd, Bowling Green, KY 42104 Phone: 270-535-1853 | |
Adair Mcalister, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5079 Scottsville Rd, Bowling Green, KY 42104 Phone: 270-999-4626 | |
Cora Spiller, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1053 Lovers Ln, Bowling Green, KY 42103 Phone: 270-807-0335 | |
Mrs. Miranda Mize Hunt, MS, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 5079 Scottsville Rd, Bowling Green, KY 42104 Phone: 270-781-2462 | |
Ashley Marie Sterchi, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: The Kid Spot Center, 944 Fields Dr. #102, Bowling Green, KY 42104 Phone: 270-495-1312 | |
Olivia Grace Jones, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 952 Fairview Ave Ste 4, Bowling Green, KY 42101 Phone: 270-938-0101 | |
Mr. Frank Trevor Polson, MSCCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Shive Ln Ste 104, Bowling Green, KY 42103 Phone: 270-576-3303 |